MDWD - MediWound reports mixed Q4 results; initiates FY24 outlook
2024-03-21 07:19:09 ET
More on MediWound
- MediWound stock climbs 9% on Phase 2 data for wound care treatment
- FDA accepts MediWound application for NexoBrid pediatric approval
- Seeking Alpha’s Quant Rating on MediWound
- Historical earnings data for MediWound
- Financial information for MediWound